Home | Exact Sciences
WEBExact Sciences Laboratories are dedicated to delivering the most accurate test results to support informed decision making. Exact Sciences’ products, services, mission, and people all work together to support early cancer detection and smarter treatment decisions.
Exact Sciences Presents Data Demonstrating Advancement in …
WEB4 days ago · MADISON, Wis., Sep. 16, 2024 – Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced performance data for its blood-based colorectal cancer (CRC) screening test. Results show sensitivities of 88.3% for CRC and 31.2% for advanced precancerous lesions at specificity of 90.1% for negative samples confirmed by colonoscopy. Results were ...
Exact Sciences Corp. - Wikipedia
WEBExact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer.
Exact Sciences Presents Data Demonstrating Advancement in …
WEB3 days ago · MADISON, Wis., September 16, 2024--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced performance data for its blood-based colorectal ...
About Us | Exact Sciences
WEBAt Exact Sciences, we’re helping eradicate cancer by preventing it, detecting it earlier, and guiding its personalized treatment. We bring together the best in visionary thinking and …
Exact Sciences Corporation (EXAS) - Yahoo Finance
WEBExact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally.
Exact Sciences Corp (EXAS) Stock Price & News - Google Finance
WEBGet the latest Exact Sciences Corp (EXAS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Exact Sciences Advances Early Cancer Detection and Precision …
WEBOct 20, 2023 · Building upon decades of research, Exact Sciences is designing the Cancerguard test to harness the additive sensitivity of multiple biomarker classes to detect more early-stage cancers.
Exact Sciences Announces Fourth Quarter 2022 Results
WEBFeb 21, 2023 · Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated revenue of $553.0 million for the fourth quarter of 2022 and $2,084.3 million for the full year of 2022, both ended Dec. 31, 2022.
Buy Rating Affirmed for Exact Sciences Following Promising CRC ...
WEB3 days ago · Founded in 1995, Wisconsin-based Exact Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer.
Skip to content